R1 RCM Inc. (“R1”), a leader in technology-driven healthcare solutions, has been named a 2025 ‘Best in KLAS’ award winner in several key categories, underscoring its capabilities in revenue cycle ...
R1 RCM (NASDAQ:RCM) agreed to be sold to TowerBrook and Clayton, Dubilier & Rice in a deal valued at $8.9 billion. R1 RCM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback